Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128739) titled 'An exploratory clinical study on short-course radiotherapy followed by Adebrelimab and chemotherapy as neoadjuvant treatment for locally advanced resectable esophageal squamous cell carcinoma' on July 24.

Study Type: Treatment study

Study Design: Single arm

Primary Sponsor: Chinese PLA General Hospital

Condition: Esophageal squamous cell carcinoma

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-08-31

Target Sample Size: Test Group:36;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=332129

Disclaimer: Curated by HT Syndicati...